Dermapharm

Dermapharm AG operates as a manufacturer and distributor of pharmaceutical products, with a strategic focus on dermatology and anti-inflammatory medicines within the Swiss healthcare market. The company was established in 1995 as the Swiss subsidiary of an international, family-run pharmaceutical group and is headquartered in Hünenberg, Canton of Zug. This parent company, Dermapharm Holding SE, was founded in 1991 by Wilhelm Beier. Beier, a trained veterinarian who later ventured into human medicine, identified an opportunity to produce and market cortisone-free dermatological drugs that were no longer protected by patents, offering them at a lower cost.

The business model centers on producing and marketing patent-free pharmaceutical products with established active ingredients. Dermapharm serves as a partner to patients, physicians, and pharmacists throughout Switzerland. Its product portfolio is segmented into three main areas: branded pharmaceuticals and other healthcare products, generics, and parallel imports. The core business revolves around branded pharmaceuticals for various therapeutic areas, particularly dermatology, gynecology, and allergy treatment. A significant portion of its revenue is generated through a portfolio of over 1,300 drug approvals. The company leverages synergies within its international corporate group, which includes its own production facilities, to achieve price advantages. This approach aims to contribute to cost reduction within the Swiss healthcare system.

As the Swiss arm of Dermapharm Holding SE, Dermapharm AG benefits from the group's broader international operations and manufacturing capabilities. The holding company pursues a strategy of internationalizing its business to tap into new markets and has a history of growth through acquisitions, such as the takeover of the French pharmaceutical company Arkopharma. The group's production facilities are located in Germany, enabling centralized development and manufacturing according to modern standards.

Keywords: pharmaceuticals, dermatology, generics, branded medicines, healthcare products, parallel imports, anti-inflammatory, Swiss market, drug manufacturing, patent-free drugs